Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 12/2018

07.08.2018 | Laboratory Investigation

Renal Denervation by Transaortic Periarterial Ethanol Injection: An Experimental Study in Porcines

verfasst von: Patrick Freyhardt, Josephine Schütze, Ricardo Donners, Jörg Schnorr, Nicola Stolzenburg, Jan L. Rinnenthal, Tobias Penzkofer, Bernd Hamm, Rolf W. Günther, Florian Streitparth

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

To evaluate the feasibility, safety and efficacy of renal sympathetic denervation via endoluminal transaortic periarterial ethanol injection.

Methods and Results

In 11 normotensive pigs transaortic puncture was performed with a 90-cm 21G needle with subsequent unilateral ethanol injection to the periarterial space. Needle placement was achieved using a 7F steerable sheath fluoroscopically positioned slightly above the renal artery origin. Blood pressure measurements and abdominal CT scans were performed immediately pre- and postintervention and 4 weeks later. After euthanasia norepinephrine concentration of both kidneys (RTNEC) was determined and renal arteries and surrounding tissues histologically examined to assess induced nerve fibre degeneration.

Results

All but one procedure were technically successful. One major complication with accidental ethanol injection into the renal artery and subsequent infarction occurred. One pig died from no intervention-related cardiac arrest. The 4-week follow-up was uneventful in the remaining 10 animals. RTNEC was significantly lower on the treated side in eight of ten pigs (mean decrease 36.6%) with correlating histopathological signs of nerve degeneration.

Conclusions

Renal sympathicolysis by transaortic periarterial ethanol injection was feasible and effective in a porcine model. This approach may be an alternative to catheter-based RFA or other methods of renal denervation.
Literatur
1.
Zurück zum Zitat Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.CrossRef Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.CrossRef
2.
Zurück zum Zitat Symplicity HTNI, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.CrossRef Symplicity HTNI, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.CrossRef
3.
Zurück zum Zitat Tsioufis CP, Papademetriou V, Dimitriadis KS, et al. Catheter-based renal denervation for resistant hypertension: twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system. Int J Cardiol. 2015;201:345–50.CrossRef Tsioufis CP, Papademetriou V, Dimitriadis KS, et al. Catheter-based renal denervation for resistant hypertension: twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system. Int J Cardiol. 2015;201:345–50.CrossRef
4.
Zurück zum Zitat Cohen-Mazor M, Mathur P, Stanley JR, et al. Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model. J Hypertens. 2014;32:1678–91 (Discussion 91–2).CrossRef Cohen-Mazor M, Mathur P, Stanley JR, et al. Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model. J Hypertens. 2014;32:1678–91 (Discussion 91–2).CrossRef
5.
Zurück zum Zitat Azizi M, Sapoval M, Gosse P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385:1957–65.CrossRef Azizi M, Sapoval M, Gosse P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385:1957–65.CrossRef
6.
Zurück zum Zitat Townsend RR, Mahfoud F, Kandzari DE, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160–70.CrossRef Townsend RR, Mahfoud F, Kandzari DE, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160–70.CrossRef
7.
Zurück zum Zitat Bhatt DL, Kandzari DE, O’Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.CrossRef Bhatt DL, Kandzari DE, O’Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.CrossRef
8.
Zurück zum Zitat Esler M. Renal denervation: not as easy as it looks. Sci Transl Med. 2015;7:285fs18.CrossRef Esler M. Renal denervation: not as easy as it looks. Sci Transl Med. 2015;7:285fs18.CrossRef
9.
Zurück zum Zitat Streitparth F, Gebauer B, Nickel P, et al. Percutaneous computer tomography-guided ethanol sympathicolysis for the treatment of resistant arterial hypertension. Cardiovasc Interv Radiol. 2014;37:513–8.CrossRef Streitparth F, Gebauer B, Nickel P, et al. Percutaneous computer tomography-guided ethanol sympathicolysis for the treatment of resistant arterial hypertension. Cardiovasc Interv Radiol. 2014;37:513–8.CrossRef
10.
Zurück zum Zitat Streitparth F, Walter A, Stolzenburg N, et al. MR-guided periarterial ethanol injection for renal sympathetic denervation: a feasibility study in pigs. Cardiovasc Interv Radiol. 2013;36(3):791–6.CrossRef Streitparth F, Walter A, Stolzenburg N, et al. MR-guided periarterial ethanol injection for renal sympathetic denervation: a feasibility study in pigs. Cardiovasc Interv Radiol. 2013;36(3):791–6.CrossRef
11.
Zurück zum Zitat Freyhardt P, Donners R, Riemert A, et al. Renal denervation by CT-guided periarterial injection of hyperosmolar saline, vincristine, paclitaxel and guanethidine in a pig model. EuroIntervention. 2017;12:e2262–70.CrossRef Freyhardt P, Donners R, Riemert A, et al. Renal denervation by CT-guided periarterial injection of hyperosmolar saline, vincristine, paclitaxel and guanethidine in a pig model. EuroIntervention. 2017;12:e2262–70.CrossRef
12.
Zurück zum Zitat Ricke J, Seidensticker M, Becker S, et al. Renal sympathetic denervation by CT-guided ethanol injection: a phase II pilot trial of a novel technique. Cardiovasc Interv Radiol. 2016;39:251–60.CrossRef Ricke J, Seidensticker M, Becker S, et al. Renal sympathetic denervation by CT-guided ethanol injection: a phase II pilot trial of a novel technique. Cardiovasc Interv Radiol. 2016;39:251–60.CrossRef
13.
Zurück zum Zitat Fischell TA, Fischell DR, Ghazarossian VE, et al. Next generation renal denervation: chemical “perivascular” renal denervation with alcohol using a novel drug infusion catheter. Cardiovasc Revasc Med. 2015;36:2219–27. Fischell TA, Fischell DR, Ghazarossian VE, et al. Next generation renal denervation: chemical “perivascular” renal denervation with alcohol using a novel drug infusion catheter. Cardiovasc Revasc Med. 2015;36:2219–27.
14.
Zurück zum Zitat Fischell TA, Vega F, Raju N, et al. Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model. EuroIntervention. 2013;9:140–7.CrossRef Fischell TA, Vega F, Raju N, et al. Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model. EuroIntervention. 2013;9:140–7.CrossRef
15.
Zurück zum Zitat Stefanadis C, Toutouzas K, Vlachopoulos C, et al. Chemical denervation of the renal artery with vincristine for the treatment of resistant arterial hypertension: first-in-man application. Hellenic J Cardiol. 2013;54:318–21.PubMed Stefanadis C, Toutouzas K, Vlachopoulos C, et al. Chemical denervation of the renal artery with vincristine for the treatment of resistant arterial hypertension: first-in-man application. Hellenic J Cardiol. 2013;54:318–21.PubMed
16.
Zurück zum Zitat Swindle MM. Comparative anatomy and physiology of the pig. Scand J Lab Anim Sci Suppl. 1998;25:1–10. Swindle MM. Comparative anatomy and physiology of the pig. Scand J Lab Anim Sci Suppl. 1998;25:1–10.
17.
Zurück zum Zitat Sakakura K, Ladich E, Edelman ER, et al. Methodological standardization for the pre-clinical evaluation of renal sympathetic denervation. JACC Cardiovasc Interv. 2014;7:1184–93.CrossRef Sakakura K, Ladich E, Edelman ER, et al. Methodological standardization for the pre-clinical evaluation of renal sympathetic denervation. JACC Cardiovasc Interv. 2014;7:1184–93.CrossRef
18.
Zurück zum Zitat Bauch HJ, Kelsch U, Hauss WH. A single, rapid, selective and quantitative determination of adrenaline and noradrenaline in the plasma by a combination of solvent extraction, HPLC separation and electrochemical detection. J Clin Chem Clin Biochem. 1986;24:651–8.PubMed Bauch HJ, Kelsch U, Hauss WH. A single, rapid, selective and quantitative determination of adrenaline and noradrenaline in the plasma by a combination of solvent extraction, HPLC separation and electrochemical detection. J Clin Chem Clin Biochem. 1986;24:651–8.PubMed
19.
Zurück zum Zitat Schonherr E, Rehwald R, Nasseri P, et al. Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria. BMJ Open. 2016;6:e009351.CrossRef Schonherr E, Rehwald R, Nasseri P, et al. Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria. BMJ Open. 2016;6:e009351.CrossRef
20.
Zurück zum Zitat Versaci F, Trivisonno A, Olivieri C, et al. Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery. J Endovasc Ther. 2014;21:191–6.CrossRef Versaci F, Trivisonno A, Olivieri C, et al. Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery. J Endovasc Ther. 2014;21:191–6.CrossRef
21.
Zurück zum Zitat Kaltenbach B, Id D, Franke JC, et al. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol. 2012;60:2694–5.CrossRef Kaltenbach B, Id D, Franke JC, et al. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol. 2012;60:2694–5.CrossRef
22.
Zurück zum Zitat Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383:622–9.CrossRef Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383:622–9.CrossRef
23.
Zurück zum Zitat Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126:2976–82.CrossRef Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126:2976–82.CrossRef
24.
Zurück zum Zitat Bakal CW, Friedland RJ, Sprayregen S, et al. Translumbar arch aortography: a retrospective controlled study of usefulness, technique, and safety. Radiology. 1991;178:225–8.CrossRef Bakal CW, Friedland RJ, Sprayregen S, et al. Translumbar arch aortography: a retrospective controlled study of usefulness, technique, and safety. Radiology. 1991;178:225–8.CrossRef
25.
Zurück zum Zitat Marcus R, Grollman JH Jr. Translumbar coronary and brachiocephalic arteriography using a modified Desilets-Hoffman sheath. Cathet Cardiovasc Diagn. 1987;13:288–90.CrossRef Marcus R, Grollman JH Jr. Translumbar coronary and brachiocephalic arteriography using a modified Desilets-Hoffman sheath. Cathet Cardiovasc Diagn. 1987;13:288–90.CrossRef
26.
Zurück zum Zitat Tzafriri AR, Mahfoud F, Keating JH, et al. Innervation patterns may limit response to endovascular renal denervation. J Am Coll Cardiol. 2014;64:1079–87.CrossRef Tzafriri AR, Mahfoud F, Keating JH, et al. Innervation patterns may limit response to endovascular renal denervation. J Am Coll Cardiol. 2014;64:1079–87.CrossRef
27.
Zurück zum Zitat Al Raisi SI, Pouliopoulos J, Barry MT, et al. Evaluation of lesion and thermodynamic characteristics of Symplicity and EnligHTN renal denervation systems in a phantom renal artery model. EuroIntervention. 2014;10:277–84.CrossRef Al Raisi SI, Pouliopoulos J, Barry MT, et al. Evaluation of lesion and thermodynamic characteristics of Symplicity and EnligHTN renal denervation systems in a phantom renal artery model. EuroIntervention. 2014;10:277–84.CrossRef
28.
Zurück zum Zitat Vink EE, Goldschmeding R, Vink A, et al. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study. Nephrol Dial Transplant. 2014;29:1608–10.CrossRef Vink EE, Goldschmeding R, Vink A, et al. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study. Nephrol Dial Transplant. 2014;29:1608–10.CrossRef
29.
Zurück zum Zitat Al Raisi SI, Barry MT, Qian P, et al. Comparison of new-generation renal artery denervation systems: assessing lesion size and thermodynamics using a thermochromic liquid crystal phantom model. EuroIntervention. 2017;13:1242–7.CrossRef Al Raisi SI, Barry MT, Qian P, et al. Comparison of new-generation renal artery denervation systems: assessing lesion size and thermodynamics using a thermochromic liquid crystal phantom model. EuroIntervention. 2017;13:1242–7.CrossRef
30.
Zurück zum Zitat Sakakura K, Ladich E, Cheng Q, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol. 2014;64:635–43.CrossRef Sakakura K, Ladich E, Cheng Q, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol. 2014;64:635–43.CrossRef
31.
Zurück zum Zitat Bertog S, Fischel TA, Vega F, et al. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model. EuroIntervention. 2017;12:e1898–906.CrossRef Bertog S, Fischel TA, Vega F, et al. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model. EuroIntervention. 2017;12:e1898–906.CrossRef
Metadaten
Titel
Renal Denervation by Transaortic Periarterial Ethanol Injection: An Experimental Study in Porcines
verfasst von
Patrick Freyhardt
Josephine Schütze
Ricardo Donners
Jörg Schnorr
Nicola Stolzenburg
Jan L. Rinnenthal
Tobias Penzkofer
Bernd Hamm
Rolf W. Günther
Florian Streitparth
Publikationsdatum
07.08.2018
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 12/2018
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-018-2045-6

Weitere Artikel der Ausgabe 12/2018

CardioVascular and Interventional Radiology 12/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.